Poster
Combination of a glycomimetic antagonist to E-selectin and CXCR4, GMI-1359, with an anti-PD-L1 antibody attenuates regulatory T Cell infiltration and accelerates time to complete response in the murine CT26 tumor model
January 1, 2016
Published in: Society for Immuno Therapy of Cancer (SITC)